Screener
Maravai LifeSciences Holdings, Inc. MRVI EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other expense | (52) | (4,062) | (144) | (4,038) |
| Loss before income taxes | (21,802) | (74,125) | (28,330) | (126,816) |
| Income tax benefit | (171) | (4,288) | (322) | (4,126) |
| Net loss | (21,631) | (69,837) | (28,008) | (122,690) |
| Net loss attributable to non-controlling interests | (9,215) | (30,246) | (11,859) | (53,154) |
| Net loss attributable to Maravai LifeSciences Holdings, Inc. | $(12,416) | $(39,591) | $(16,149) | $(69,536) |
| Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., basic and diluted | $(0.08) | $(0.27) | $(0.11) | $(0.48) |
| Weighted average number of Class A common shares outstanding, basic and diluted | 147,996 | 144,236 | 147,215 | 143,833 |
Item 1. Financial Statements
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s EPS (diluted)?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported EPS (diluted) of -$0.08 in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s EPS (diluted) changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s EPS (diluted) increased by 70.4% year-over-year, from -$0.27 to -$0.08.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s EPS (diluted) has grown at a -12.7% compound annual growth rate (CAGR), from $1.55 to -$0.90.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude